Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 09:29
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Rishilase Sees Steady Growth in Gross Margin, Revenue Growth, and Marginal Operating Leverage.
The company's gross margin accelerated to , up from 3.48%. Revenue growth accelerated to , up from -73.4%. Marginal operating leverage also accelerated to , up from 1.48%.
On the other hand, daily trading volume moved to , down from 10764 shares. The close price remained unchanged at .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 49.85 % | 3.48 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 3.48 % | 1.48 | ▲ |
| REVENUE_GROWTH_YOY | 3 % | -73.4 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 6,242 shares | 10,764 | ▼ |
| CLOSE_PRICE | 140 INR | 140 | - |
Cite this
Source: Samhati evidence synthesis for RISHILASE (2026-10-21). Observation: Rishilase Sees Steady Growth in Gross Margin, Revenue Growth, and Marginal Operating Leverage. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/rishilase
Filing step-changes